Portland, OR -- (SBWIRE) -- 10/24/2017 -- Skin diagnosis systems are equipment used for diagnosis of each skin type. They act as a very useful tool for healthcare and beauty professionals. These systems are used by healthcare professionals and dermatologists to detect skin cancer and different skin disorders. Treatment of skin disorders using skin diagnosis systems result into complete skin rejuvenation and reduction in the risk of skin cancer.

Increase in frequency aesthetic procedures, rise in incidence of skin disorders, and growth in healthcare expenditure boosts the market growth. However, an uncertain reimbursement scenario and stringent government regulations are anticipated to hamper the growth of this market.

Get the sample copy of this report: https://www.alliedmarketresearch.com/request-toc-and-sample/2767

The global skin diagnosis system sales market is segmented on the basis of type, application end users, and geography. Based on type, it is divided into imaging devices, dermatoscopes, and microscopes. Based on application, this market is bifurcated into skin cancer diagnosis and other diagnostic applications On the basis of end user, it is classified into hospitals, clinics, beauty salons, and others.

Make a purchase enquiry: https://www.alliedmarketresearch.com/purchase-enquiry/2767

Comprehensive competitive analysis and profiles of major market players such as Alma Lasers, Ltd., Cutera, Inc., Lumenis, Ltd., Cynosure, Inc., Photomedex, Inc., Valeant Pharmaceuticals International, Inc., Bruker Corporation, Carl Zeiss, Heine Optotechnik GmbH & Co. Kg, and Genesis Biosystems, Inc. is also provided in this report.

Skin Diagnosis System Sales Market Key Segments:

By Type

-Imaging Devices
-Dermatoscopes
-Microscopes

By Application

-Skin Cancer Diagnosis
-Other Diagnostic Applications

By End User

-Hospitals
-Clinics
-Beauty Salons
-Others